BioHiTech Global Accounts Payable

BioHiTech Global posts a accounts payable of $3.7M as of September 2021. That compares with $6.4M in the prior-year period — down 41.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, BioHiTech Global's accounts payable was $6.4M. The latest reading is $3.7M — a 41.7% year-over-year decrease (period ending September 2021). Use the history and growth charts on this page for a longer lookback.

Accounts Payable is one piece of BioHiTech Global's financial statement story. At $3.7M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BHTG's accounts payable usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; BioHiTech Global's other metric pages and overview cover the third.

Judging BioHiTech Global against Utilities peers is usually better than using a market-wide rule of thumb. Business models inside Utilities are more comparable, which makes gaps in accounts payable easier to interpret. Start with $3.7M here, then scan peer and history charts to see if the gap is persistent.